Safety-77-arkiv - Biosector Ltd.

Editorial illustration showing drug discovery evolving from primitive narrow target panels, through patient risk, toward modern mass spectrometry based off-target profiling and healthier treatment outcomes.

by Stefan Sandström

Modern Off-Target Profiling: The Murderous Reality Behind Clean Safety Panels

The Easy Hurdle That Kills Programs A drug candidate can clear the standard off-target panel and […]

0